1. Home
  2. EXEL vs SWKS Comparison

EXEL vs SWKS Comparison

Compare EXEL & SWKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • SWKS
  • Stock Information
  • Founded
  • EXEL 1994
  • SWKS 1962
  • Country
  • EXEL United States
  • SWKS United States
  • Employees
  • EXEL 1147
  • SWKS N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • SWKS Semiconductors
  • Sector
  • EXEL Health Care
  • SWKS Technology
  • Exchange
  • EXEL Nasdaq
  • SWKS Nasdaq
  • Market Cap
  • EXEL 10.4B
  • SWKS 10.2B
  • IPO Year
  • EXEL 2000
  • SWKS 1968
  • Fundamental
  • Price
  • EXEL $38.31
  • SWKS $74.52
  • Analyst Decision
  • EXEL Buy
  • SWKS Hold
  • Analyst Count
  • EXEL 21
  • SWKS 18
  • Target Price
  • EXEL $43.65
  • SWKS $72.69
  • AVG Volume (30 Days)
  • EXEL 4.0M
  • SWKS 2.7M
  • Earning Date
  • EXEL 07-28-2025
  • SWKS 08-05-2025
  • Dividend Yield
  • EXEL N/A
  • SWKS 3.76%
  • EPS Growth
  • EXEL 81.76
  • SWKS N/A
  • EPS
  • EXEL 2.08
  • SWKS 2.50
  • Revenue
  • EXEL $2,230,005,000.00
  • SWKS $4,011,700,000.00
  • Revenue This Year
  • EXEL $9.88
  • SWKS N/A
  • Revenue Next Year
  • EXEL $12.59
  • SWKS N/A
  • P/E Ratio
  • EXEL $18.45
  • SWKS $29.77
  • Revenue Growth
  • EXEL 10.73
  • SWKS N/A
  • 52 Week Low
  • EXEL $25.12
  • SWKS $47.93
  • 52 Week High
  • EXEL $49.62
  • SWKS $110.76
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 41.08
  • SWKS 59.99
  • Support Level
  • EXEL $37.01
  • SWKS $70.33
  • Resistance Level
  • EXEL $38.78
  • SWKS $70.87
  • Average True Range (ATR)
  • EXEL 1.12
  • SWKS 2.40
  • MACD
  • EXEL 0.07
  • SWKS 0.70
  • Stochastic Oscillator
  • EXEL 83.79
  • SWKS 86.81

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About SWKS Skyworks Solutions Inc.

Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.

Share on Social Networks: